14698201 15013004 15378131 12700003 25847280 17493093 15831843 12501118 26631004 27465696 35056088 12708620 19343122 22797310 16620147 15965360 11772326 12808481 15694741 35007384 15546720 16379914 15285695 - Search Results

Year	Number of Results
2002	2
2003	3
2004	6
2005	3
2006	1
2007	1
2008	1
2012	1
2015	2
2016	1
2017	1
2021	1
2022	1
2023	0

1

New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties.

Koltun DO, Marquart TA, Shenk KD, Elzein E, Li Y, Nguyen M, Kerwar S, Zeng D, Chu N, Soohoo D, Hao J, Maydanik VY, Lustig DA, Ng KJ, Fraser H, Zablocki JA. Koltun DO, et al. Bioorg Med Chem Lett. 2004 Jan 19;14(2):549-52. doi: 10.1016/j.bmcl.2003.09.093. Bioorg Med Chem Lett. 2004. PMID: 14698201

2

Novel inhibitors of fatty acid oxidation as potential metabolic modulators.

Elzein E, Shenk K, Ibrahim P, Marquart T, Kerwar S, Meyer S, Ahmed H, Zeng D, Chu N, Soohoo D, Wong S, Leung K, Zablocki J. Elzein E, et al. Bioorg Med Chem Lett. 2004 Feb 23;14(4):973-7. doi: 10.1016/j.bmcl.2003.11.065. Bioorg Med Chem Lett. 2004. PMID: 15013004

3

Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.

Chaitman BR. Chaitman BR. J Cardiovasc Pharmacol Ther. 2004 Sep;9 Suppl 1:S47-64. doi: 10.1177/107424840400900105. J Cardiovasc Pharmacol Ther. 2004. PMID: 15378131

4

Heart metabolic disturbances in cardiovascular diseases.

Carvajal K, Moreno-Sánchez R. Carvajal K, et al. Arch Med Res. 2003 Mar-Apr;34(2):89-99. doi: 10.1016/S0188-4409(03)00004-3. Arch Med Res. 2003. PMID: 12700003 Review.

5

Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.

Görgens C, Guddat S, Dib J, Geyer H, Schänzer W, Thevis M. Görgens C, et al. Drug Test Anal. 2015 Nov-Dec;7(11-12):973-9. doi: 10.1002/dta.1788. Epub 2015 Apr 5. Drug Test Anal. 2015. PMID: 25847280 Free PMC article.

6

Ranolazine: a novel agent that improves dysfunctional sodium channels.

Pham DQ, Mehta M. Pham DQ, et al. Int J Clin Pract. 2007 May;61(5):864-72. doi: 10.1111/j.1742-1241.2007.01348.x. Int J Clin Pract. 2007. PMID: 17493093 Review.

7

Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies.

Sanoudou D, Vafiadaki E, Arvanitis DA, Kranias E, Kontrogianni-Konstantopoulos A. Sanoudou D, et al. Physiol Genomics. 2005 Apr 14;21(2):131-43. doi: 10.1152/physiolgenomics.00259.2004. Physiol Genomics. 2005. PMID: 15831843 Review.

8

Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor.

Chaitman BR. Chaitman BR. Curr Probl Cardiol. 2002 Dec;27(12):527-55. doi: 10.1067/mcn.2002.129438. Curr Probl Cardiol. 2002. PMID: 12501118 Review. No abstract available.

9

C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes.

Alkofide H, Huggins GS, Beshansky JR, Ruthazer R, Peter I, Ray M, Mukherjee JT, Selker HP. Alkofide H, et al. BMC Cardiovasc Disord. 2015 Dec 3;15:163. doi: 10.1186/s12872-015-0153-7. BMC Cardiovasc Disord. 2015. PMID: 26631004 Free PMC article. Clinical Trial.

10

Story behind meldonium-from pharmacology to performance enhancement: a narrative review.

Schobersberger W, Dünnwald T, Gmeiner G, Blank C. Schobersberger W, et al. Br J Sports Med. 2017 Jan;51(1):22-25. doi: 10.1136/bjsports-2016-096357. Epub 2016 Jul 27. Br J Sports Med. 2017. PMID: 27465696 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results